Ceremonies on Cornell’s Ithaca and Weill Cornell Medicine campuses honored not only academic achievement, but the resilience, shared purpose and commitment to lifelong learning that define Cornell staff.
Cornell Prime dots – known as C’ dots – are effective against prostate tumors, according to a new preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering.
A new prodrug offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.
A circuit that runs from the prefrontal cortex to the insular cortex appears to mediate the antidepressant effects of a newer form of transcranial magnetic stimulation, according to a study led by Weill Cornell Medicine investigators.
Extreme heat and cold are growing cardiovascular risks that can trigger heart attacks, strokes, heart failure and sudden cardiac death, according to a recent scientific statement by experts at Weill Cornell Medicine and other leading institutions.
A new technology allows scientists to map the DNA-binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by Weill Cornell Medicine and the New York Genome Center.
A clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment.
Weill Cornell Medicine received a five-year, $5 million grant from the National Cancer Institute to develop innovative support strategies for an understudied group of cancer patients: adolescents and young adults.
